Gastrointestinal Neoplasm
15
4
4
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 15 trials
100.0%
+13.5% vs benchmark
7%
1 trials in Phase 3/4
25%
2 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (15)
Novel Rigidizing Overtube in Colonic Endoscopic Submucosal Dissection
Traction vs. No Traction in Colonic ESD
AI for Onsite Cytology Evaluation in Endoscopic Ultrasound
The ctDNA-RECIST Trial Part One
Prospective Cohort Study on the Safety and Efficacy of Endorobotics for Endoscopic Submucosal Dissection (Endorobotics ESD)
Disposable Powered Articulating Linear Cutter Stapler in Gastrointestinal Tissue Cutting and Anastomosis
A Study of XmAb®18087 in Subjects With NET and GIST
Primary Tumour Response to Induction Chemotherapy in Synchronously Metastasized Colorectal Cancer
Kinase Genotyping of Gastro Intestinal Stomach Tumors (GISTs) From Patients Enrolled in Pfizer A6181112 Phase IIIb Trial
First Line Study of Irinotecan, Capecitabine and Oxaliplatin in Metastatic Gastric or Gastroesophageal Cancer.
Endorings™ Assisted Colonoscopy Versus Standard Colonoscopy for Polyp Detection
Assessing the Patient Experience in Cancer Care
Debulking and Chemotherapy With or Without Intraperitoneal Chemotherapy to Treat Peritoneal Carcinomatosis
A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248
A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors